Cargando…
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
Containment of highly lethal Ebola virus outbreaks poses a serious public health challenge. Although an experimental vaccine has successfully protected non-human primates against disease(1), more than six months was required to complete the immunizations, making it impractical to limit an acute epid...
Autores principales: | Sullivan, Nancy J., Geisbert, Thomas W., Geisbert, Joan B., Xu, Ling, Yang, Zhi-yong, Roederer, Mario, Koup, Richard A., Jahrling, Peter B., Nabel, Gary J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095492/ https://www.ncbi.nlm.nih.gov/pubmed/12904795 http://dx.doi.org/10.1038/nature01876 |
Ejemplares similares
-
Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs
por: Sullivan, Nancy J, et al.
Publicado: (2006) -
Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
por: Geisbert, Thomas W., et al.
Publicado: (2002) -
Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys
por: Oswald, Wendelien B, et al.
Publicado: (2007) -
Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
por: Mire, Chad E., et al.
Publicado: (2016) -
Marburg and Ebola Hemorrhagic Fevers (Filoviruses)
por: Geisbert, Thomas W.
Publicado: (2015)